U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849102) titled 'NeuroReAlign Therapy for Balance and Gait Rehabilitation in Stroke Survivors' on Feb. 20.
Brief Summary: The goal of this randomized controlled trial is to investigate the effects of NeuroReAlign Therapy on balance and gait in stroke survivors in the chronic stage (>6 months). The study will include male and female participants aged 18-70 years.
The main questions it aims to answer are:
Does NeuroReAlign Therapy improve balance in stroke survivors compared to conventional physiotherapy? Does NeuroReAlign Therapy enhance gait performance more effectively than conventional physiotherapy? Researchers will compare NeuroReAlign Therapy...